Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

The INO80 remodeller in transcription, replication and repair.

Poli J, Gasser SM, Papamichos-Chronakis M.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 5;372(1731). pii: 20160290. doi: 10.1098/rstb.2016.0290. Review.

PMID:
28847827
2.
3.

Genomewide Analysis of Clp1 Function in Transcription in Budding Yeast.

Al-Husini N, Sharifi A, Mousavi SA, Chitsaz H, Ansari A.

Sci Rep. 2017 Jul 31;7(1):6894. doi: 10.1038/s41598-017-07062-6.

4.

Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer.

Warburton AJ, Boone DN.

Curr Pathobiol Rep. 2017 Mar;5(1):23-34. doi: 10.1007/s40139-017-0122-1. Epub 2017 Jan 23.

5.

Transcriptional landscape of the human cell cycle.

Liu Y, Chen S, Wang S, Soares F, Fischer M, Meng F, Du Z, Lin C, Meyer C, DeCaprio JA, Brown M, Liu XS, He HH.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3473-3478. doi: 10.1073/pnas.1617636114. Epub 2017 Mar 13.

PMID:
28289232
6.

Catalytic-Independent Functions of PARP-1 Determine Sox2 Pioneer Activity at Intractable Genomic Loci.

Liu Z, Kraus WL.

Mol Cell. 2017 Feb 16;65(4):589-603.e9. doi: 10.1016/j.molcel.2017.01.017.

PMID:
28212747
7.

An Intrinsic Transcriptional Program Underlying Synaptic Scaling during Activity Suppression.

Schaukowitch K, Reese AL, Kim SK, Kilaru G, Joo JY, Kavalali ET, Kim TK.

Cell Rep. 2017 Feb 7;18(6):1512-1526. doi: 10.1016/j.celrep.2017.01.033.

8.

RNA Binding to CBP Stimulates Histone Acetylation and Transcription.

Bose DA, Donahue G, Reinberg D, Shiekhattar R, Bonasio R, Berger SL.

Cell. 2017 Jan 12;168(1-2):135-149.e22. doi: 10.1016/j.cell.2016.12.020. Epub 2017 Jan 12.

PMID:
28086087
9.

Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.

Rahman S, Zorca CE, Traboulsi T, Noutahi E, Krause MR, Mader S, Zenklusen D.

Nucleic Acids Res. 2017 Apr 7;45(6):3017-3030. doi: 10.1093/nar/gkw1220.

10.
11.

miRNA clusters as therapeutic targets for hormone-resistant breast cancer.

Di Leva G, Cheung DG, Croce CM.

Expert Rev Endocrinol Metab. 2015;10(6):607-617. Epub 2015 Oct 13.

12.

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.

Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, Prensner JR, Poliakov A, Singhal U, Xiao L, Kregel S, Siebenaler RF, Zhao SG, Uhl M, Gawronski A, Hayes DF, Pierce LJ, Cao X, Collins C, Backofen R, Sahinalp CS, Rae JM, Chinnaiyan AM, Feng FY.

Nat Commun. 2016 Sep 26;7:12791. doi: 10.1038/ncomms12791.

13.

Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers.

Nagari A, Murakami S, Malladi VS, Kraus WL.

Methods Mol Biol. 2017;1468:121-38. doi: 10.1007/978-1-4939-4035-6_10.

14.

Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.

Toropainen S, Niskanen EA, Malinen M, Sutinen P, Kaikkonen MU, Palvimo JJ.

Sci Rep. 2016 Sep 19;6:33510. doi: 10.1038/srep33510.

15.

CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.

Fiorito E, Sharma Y, Gilfillan S, Wang S, Singh SK, Satheesh SV, Katika MR, Urbanucci A, Thiede B, Mills IG, Hurtado A.

Nucleic Acids Res. 2016 Dec 15;44(22):10588-10602. Epub 2016 Sep 15.

16.

Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage.

Stork CT, Bocek M, Crossley MP, Sollier J, Sanz LA, Chédin F, Swigut T, Cimprich KA.

Elife. 2016 Aug 23;5. pii: e17548. doi: 10.7554/eLife.17548.

17.

The bright side of dark matter: lncRNAs in cancer.

Evans JR, Feng FY, Chinnaiyan AM.

J Clin Invest. 2016 Aug 1;126(8):2775-82. doi: 10.1172/JCI84421. Epub 2016 Aug 1. Review.

18.

Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq).

Mahat DB, Kwak H, Booth GT, Jonkers IH, Danko CG, Patel RK, Waters CT, Munson K, Core LJ, Lis JT.

Nat Protoc. 2016 Aug;11(8):1455-76. doi: 10.1038/nprot.2016.086. Epub 2016 Jul 21.

19.

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.

Milevskiy MJ, Al-Ejeh F, Saunus JM, Northwood KS, Bailey PJ, Betts JA, McCart Reed AE, Nephew KP, Stone A, Gee JM, Dowhan DH, Dray E, Shewan AM, French JD, Edwards SL, Clark SJ, Lakhani SR, Brown MA.

Hum Mol Genet. 2016 Aug 1;25(15):3269-3283. doi: 10.1093/hmg/ddw177. Epub 2016 Jul 4.

20.

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer.

Zhao J, Zhao Y, Wang L, Zhang J, Karnes RJ, Kohli M, Wang G, Huang H.

Oncotarget. 2016 Jun 21;7(25):38551-38565. doi: 10.18632/oncotarget.9535.

Supplemental Content

Support Center